IRIS - Institutional Research Information System
IRIS è il sistema di gestione integrata dei dati della ricerca (persone, progetti, pubblicazioni, attività) adottato dall'Università degli Studi dell’Insubria.

IRInSubria - Institutional Repository Insubria
IRInSubria raccoglie, conserva, documenta e dissemina le informazioni sulla produzione scientifica dell'Università degli Studi dell’Insubria anche ai fini della valutazione della ricerca.

BARTALENA, LUIGI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 24.142
EU - Europa 13.630
AS - Asia 7.086
SA - Sud America 853
AF - Africa 78
Continente sconosciuto - Info sul continente non disponibili 43
OC - Oceania 22
AN - Antartide 1
Totale 45.855
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 23.975
IT - Italia 6.344
UA - Ucraina 2.450
SG - Singapore 2.245
TR - Turchia 1.423
CN - Cina 1.151
DE - Germania 988
SE - Svezia 971
VN - Vietnam 967
HK - Hong Kong 886
BR - Brasile 711
IE - Irlanda 697
FI - Finlandia 616
GB - Regno Unito 607
RU - Federazione Russa 418
FR - Francia 130
IN - India 106
CA - Canada 104
JP - Giappone 95
NL - Olanda 56
AR - Argentina 50
MX - Messico 49
PL - Polonia 47
AT - Austria 46
ES - Italia 46
EU - Europa 41
BE - Belgio 36
CZ - Repubblica Ceca 36
BD - Bangladesh 35
ZA - Sudafrica 30
LT - Lituania 28
CL - Cile 24
ID - Indonesia 22
IQ - Iraq 22
EC - Ecuador 21
PK - Pakistan 21
CH - Svizzera 20
IL - Israele 16
RO - Romania 14
NZ - Nuova Zelanda 13
UZ - Uzbekistan 13
CO - Colombia 12
AE - Emirati Arabi Uniti 11
MA - Marocco 10
SA - Arabia Saudita 10
VE - Venezuela 10
EG - Egitto 9
NP - Nepal 9
PY - Paraguay 9
AU - Australia 8
BG - Bulgaria 8
BY - Bielorussia 8
HU - Ungheria 8
PE - Perù 8
DK - Danimarca 7
KE - Kenya 7
MY - Malesia 7
HR - Croazia 5
KR - Corea 5
LU - Lussemburgo 5
NO - Norvegia 5
PT - Portogallo 5
RS - Serbia 5
TN - Tunisia 5
UY - Uruguay 5
AZ - Azerbaigian 4
BA - Bosnia-Erzegovina 4
EE - Estonia 4
GR - Grecia 4
MD - Moldavia 4
PA - Panama 4
SK - Slovacchia (Repubblica Slovacca) 4
BN - Brunei Darussalam 3
DZ - Algeria 3
HN - Honduras 3
JM - Giamaica 3
KW - Kuwait 3
LK - Sri Lanka 3
OM - Oman 3
SI - Slovenia 3
TH - Thailandia 3
TZ - Tanzania 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
BH - Bahrain 2
BO - Bolivia 2
CI - Costa d'Avorio 2
IR - Iran 2
JO - Giordania 2
KG - Kirghizistan 2
KH - Cambogia 2
MM - Myanmar 2
PH - Filippine 2
SN - Senegal 2
AQ - Antartide 1
BT - Bhutan 1
CG - Congo 1
CV - Capo Verde 1
DO - Repubblica Dominicana 1
GA - Gabon 1
Totale 45.839
Salva come PNG Salva come JPEG
Città #
Milan 4.548
Fairfield 3.210
Jacksonville 1.890
Woodbridge 1.867
Ashburn 1.858
Chandler 1.659
Houston 1.365
Seattle 1.329
Wilmington 1.241
Singapore 1.204
Cambridge 1.075
Dearborn 1.071
Ann Arbor 969
Dallas 931
Hong Kong 878
Izmir 724
Dublin 686
Princeton 674
Nyköping 416
Dong Ket 408
Boardman 396
Beijing 341
Rome 335
Como 237
San Mateo 237
Chicago 211
New York 210
San Diego 201
The Dalles 179
Los Angeles 140
Ogden 122
London 103
Tokyo 90
Düsseldorf 86
Hefei 82
São Paulo 80
Santa Clara 78
Kunming 76
Washington 69
Zhengzhou 67
Munich 63
Ho Chi Minh City 60
Kocaeli 60
Nanjing 60
Norwalk 60
Hanoi 50
Redmond 50
Warsaw 43
Guangzhou 39
Helsinki 39
Frankfurt am Main 38
Shanghai 37
Brussels 35
Jinan 33
Montreal 33
Toronto 33
Denver 32
Stockholm 32
San Francisco 31
Verona 31
Brooklyn 29
Orem 29
Brno 28
Phoenix 26
Vienna 26
Atlanta 25
Mexico City 25
Nanchang 25
Poplar 23
Rio de Janeiro 22
Pune 21
Johannesburg 20
North Bergen 20
Amsterdam 19
Turku 19
Kilburn 18
Madrid 18
Manchester 18
Chennai 17
Berlin 16
Varese 16
Ankara 15
Boston 15
Buffalo 15
Edinburgh 15
Nuremberg 15
Curitiba 14
Hebei 14
Shenyang 14
Chengdu 13
Redwood City 13
Tampa 13
Belo Horizonte 12
Buenos Aires 12
Miami 12
Salt Lake City 12
Acton 11
Changsha 11
Columbus 11
Tashkent 11
Totale 32.910
Salva come PNG Salva come JPEG
Nome #
Vitreous Substitutes: The Present and the Future. 275
A teleconsultation network improves the efficacy of anti-VEGF therapy in retinal diseases. 261
Macular hole surgery: The healing process of outer retinal layers to visual acuity recovery 255
Simultaneous medullary and papillary thyroid cancer: two case reports. 234
A 2013 European survey of clinical practice patterns in the management of Graves' disease 231
Masked hypertension in newly diagnosed hypothyroidism: a pilot study 228
Process to radioactive iodine treatment for Graves' hyperthyroidism: condemned or absolved? 227
The phenotype of newly diagnosed Graves’ disease in Italy in recent years is milder than in the past: results of a large observational longitudinal study 224
Antithyroid drug treatment for Graves’ disease: baseline predictive models of relapse after treatment for a patient-tailored management 220
Cardiometabolic healthy and unhealthy obesity: does vitamin D play a role? 215
Subclinical hypothyroidism and deep venous thrombosis. A pilot cross-sectional study 211
PREGO (presentation of Graves' orbitopathy) study: changes in referral patterns to European Group On Graves' Orbitopathy (EUGOGO) centres over the period from 2000 to 2012 200
The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy 200
Graves' hyperthyroidism of recent onset and Graves' orbitopathy: to ablate or not to ablate the thyroid? 199
Nutrizione iodica e ipertiroidismo: quello che c’è da sapere 197
Pituitary apoplexy during pregnancy: A rare, but dangerous headache 197
Immunomodulatory effect of vitamin D and its potential role in the prevention and treatment of thyroid autoimmunity: a narrative review 196
Consensus Statement of the European Group on Graves' Orbitopathy (EUGOGO) on Management of Graves' Orbitopathy 195
Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO 193
Can combination of glucocorticoids with other immunosoppressive drugs reduce the cumulative dose of glucocorticoids for moderate-to-severe and active Graves' orbitopathy? 193
Absence of serum thyroid hormone autoantibodies in patients chronically treated with amiodarone 191
Can a patient-tailored treatment approach for Graves' disease reduce mortality? 189
Outcome prediction of treatment of Graves' hyperthyroidism with antithyroid drugs 188
Oral steroid prophylaxis for Graves' orbitopathy after radioactive iodine treatment for Graves' disease is not only effective, but also safe 188
Lower dose prednisone prevents radioiodine-associated exacerbation of initially mild or absent Graves' orbitopathy: a retrospective cohort study 186
Physical performance in newly diagnosed hypothyroidism: a pilot study 184
Time interval in diagnosis and treatment of papillary thyroid cancer: a descriptive, retrospective study 184
Amiodarone iodine-induced hypothyroidism: risk factors and follow-up in 28 cases 183
Serum TSH measurements by a sensitive enzyme immunoassay discriminate euthyroid from hyperthyroid subjects and avoid the need for TRH test during suppressive therapy with L-thyroxine 183
Effects of selenium on short-term control of hyperthyroidism due to Graves' disease treated with methimazole: results of a randomized clinical trial 182
Plasma total and acylated ghrelin concentrations in patients with clinical and subclinical thyroid dysfunction 180
Adjuvant effect of lithium on radioiodine treatment of hyperthyroidism 179
Features and outcome of differentiated thyroid carcinoma associated with Graves' disease: results of a large, retrospective, multicenter study 179
Characteristics of a nationwide cohort of patients presenting with isolated hypogonadotropic hypogonadism (IHH) 178
Lack of nocturnal serum thyrotropin surge after surgery 177
Pain perception, blood pressure levels, and peripheral benzodiazepine receptors in patients followed for differentiated thyroid carcinoma: a longitudinal study in hypothyroidism and during hormone treatment 176
Does early response to intravenous glucocorticoids predict the final outcome in patients with moderate-to-severe and active Graves’ orbitopathy? 176
The clinical enigma of the “Flea catcher” by Georges de La Tour: a pregnant sinner with pre-eclampsia or a hypothyroid girl? 176
The presence of anti-thyroglobulin (TgAb) and/or anti-thyroperoxidase antibodies (TPOAb) does not exclude the diagnosis of type 2 amiodarone-induced thyrotoxicosis. 175
Interference of thyroglobulin in TSAb detection by radioreceptor assay 174
Studies on the occurrence of ophthalmopathy in Graves' disease 173
Radioactive iodine thyroid uptake in patients with amiodarone iodine-induced thyroid dysfunction 173
More on smoking habits and Graves' ophthalmopathy 173
Maria Carolina of Austria, Queen of Naples and Sicily: a possible case of Graves' orbitopathy 173
Iodine supplementation in women of reproductive age: a survey of clinical practice among Italian gynecologists and midwives 173
Medullary thyroid carcinoma: surgical treatment advances 173
The effect of altered thyroid function on serum fructosamine concentrations 172
An update on medical management of Graves' ophthalmopathy 172
Impact of lithium on efficacy of radioactive iodine therapy for Graves' disease: a cohort study on cure rate, time to cure, and frequency of increased serum thyroxine after antithyroid drug withdrawal 172
Graves' orbitopathy: do not give it for granted 172
Diagnosis and management of amiodarone-induced thyrotoxicosis in Europe: results of an international survey among members of the European Thyroid Association 171
Amiodarone and the thyroid 171
Predictive score for the development or progression of Graves' orbitopathy in patients with newly diagnosed Graves' hyperthyroidism 171
Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy. 170
Characterization of nascent and secreted thyroxine-binding globulin in cultured human hepatoma (Hep G2) cells 169
The course of Graves' ophthalmopathy is not influenced by near total thyroidectomy: a case-control study 165
Free thyroxine values in dried blood spots on filter paper in newborns are related to both gestational age and birth body weight 165
Thyroid hormone treatment for differentiated thyroid carcinoma: What drug, how long, what dose? 165
Graves' disease and Turner's syndrome 164
Shortening Hospital Stay for Thyroid Surgery. 164
Effects of total thyroid ablation versus near-total thyroidectomy alone on mild to moderate Graves' orbitopathy treated with intravenous glucocorticoids 163
Effects of treatment modalities for Graves' hyperthyroidism on Graves' orbitopathy: a 2015 Italian Society of Endocrinology consensus statement 163
Diagnosis of amiodarone iodine-induced thyrotoxicosis (AIIT) associated with severe nonthyroidal illness 162
Prevalence and natural history of Graves' orbitopathy in a large series of patients with newly diagnosed Graves' hyperthyroidism seen at a single center 162
Graves' orbitopathy: imperfect treatments for a rare disease 162
Human serum thyrotrophin measurement by ultrasensitive immunoradiometric assay as a first-line test in the evaluation of thyroid function 161
Radioiodine therapy and Graves' ophthalmopathy 161
Recommendations for treatment of hypothyroidism with levothyroxine and levotriiodothyronine: a 2016 position statement of the Italian Society of Endocrinology and the Italian Thyroid Association 161
2018 European Thyroid Association (ETA) Guidelines for the Management of Amiodarone-Associated Thyroid Dysfunction 161
Factors affecting suppression of endogenous thyrotropin secretion by thyroxine treatment: retrospective analysis in athyreotic and goitrous patients 160
Changes in radioimmunoassayable prealbumin (TBPA) serum levels from birth to adulthood 160
Management of Graves' ophthalmopathy: reality and perspectives 160
Effects of the antileukemic drug L-asparaginase on sex-hormone binding globulin: studies in vivo and in vitro 159
Comparison between thyroid-stimulating and TSH-binding inhibiting immunoglobulins of Graves' disease 159
Radioimmunoassay of thyroid hormones 157
Effect of the antileukemic agent L-asparaginase on thyroxine-binding globulin and albumin synthesis in cultured human hepatoma (Hep G2) cells 157
Effect of amiodarone on circulating antithyroid antibodies 157
Novel treatment modalities for Graves' orbitopathy 157
Cigarette smoking: Number one enemy for Graves ophthalmopathy 157
Graves'-like orbitopathy: do not forget IgG4-related disease 157
Potassium perchlorate only temporarily restores euthyroidism in patients with amiodarone-induced hypothyroidism who continue amiodarone therapy 156
Orbital radiotherapy for Graves' ophthalmopathy 156
Graves’ orbitopathy as a rare disease in Europe: a European Group on Graves’ Orbitopathy (EUGOGO) position statement 156
Add-On Effect of Selenium and Vitamin D Combined Supplementation in Early Control of Graves’ Disease Hyperthyroidism During Methimazole Treatment 156
Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: Results of a prospective, single-blind, randomized study 155
Thyroid vascularity and blood flow are not dependent on serum thyroid hormone levels:studies in vivo by color flow Doppler sonography 155
Thyroid hormone and thyrotropin regulate intracellular free calcium concentrations in human polymorphonuclear leukocytes: in vivo and in vitro studies 155
Biosynthesis of a novel thyroxine-binding protein (27 K protein) in human hepatoma (Hep G2) cells 154
The age of patients with thyrotoxicosis factitia in Italy from 1973 to 1996 153
Ontogeny of nyctohemeral variations of thyrotropin-releasing hormone in rat hypothalamus 153
Thyroid hormone regulation of cell migration and oxidative metabolism in polymorphonuclear leukocytes: clinical evidence in thyroidectomized subjects on thyroxine replacement therapy. 152
Measurement of thyroid cell surface antibodies by radioassay using human cultured thyroid cells 151
Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidism 151
Long-term safety of orbital radiotherapy for Graves' ophthalmopathy 151
An update on the pharmacological management of hyperthyroidism due to Graves' disease 151
Treating Graves' orbitopathy: where are we? 151
Effects of amiodarone, thyroid hormones and CYP2C9 and VKORC1 polymorphisms on warfarin metabolism: a review of the literature 151
Graves' ophthalmopathy 151
Polymorphism of human thyroxine-binding globulin 150
High prevalence of subacute thyroiditis during summer season in Italy 150
Totale 17.634
Salva come PNG Salva come JPEG
Categoria #
all - tutte 186.761
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 186.761
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.929 0 0 0 0 0 638 392 472 815 313 495 804
2021/20223.581 376 465 262 133 196 144 175 183 265 569 306 507
2022/20234.398 496 246 391 422 319 949 4 540 582 150 178 121
2023/20247.478 1.101 1.179 1.141 1.443 1.532 496 52 157 188 54 23 112
2024/20254.421 20 64 889 105 103 243 200 365 466 292 342 1.332
2025/20264.839 693 730 747 1.311 1.010 348 0 0 0 0 0 0
Totale 46.101